Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review

K Asadi, A Gholami - International journal of biological macromolecules, 2021 - Elsevier
Vaccination is the most effective means of controlling infectious disease-related morbidity
and mortality. However, due to low immunogenicity of viral antigens, nanomedicine as a …

[HTML][HTML] Nano-microparticle platforms in developing next-generation vaccines

G Cappellano, H Abreu, C Casale, U Dianzani… - Vaccines, 2021 - mdpi.com
The first vaccines ever made were based on live-attenuated or inactivated pathogens, either
whole cells or fragments. Although these vaccines required the co-administration of antigens …

[HTML][HTML] Emerging vaccine nanotechnology: from defense against infection to sniping cancer

C Feng, Y Li, BE Ferdows, DN Patel, J Ouyang… - … Pharmaceutica Sinica B, 2022 - Elsevier
Looking retrospectively at the development of humanity, vaccination is an unprecedented
medical landmark that saves lives by harnessing the human immune system. During the …

Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies

L Du, Y Yang, X Zhang, F Li - Nanoscale, 2022 - pubs.rsc.org
COVID-19 has caused a global pandemic and millions of deaths. It is imperative to develop
effective countermeasures against the causative viral agent, SARS-CoV-2 and its many …

[HTML][HTML] Nanomedicine strategies to target coronavirus

MA Heinrich, B Martina, J Prakash - Nano Today, 2020 - Elsevier
With the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002, the middle
east respiratory syndrome CoV (MERS-CoV) in 2012 and the recently discovered SARS …

[HTML][HTML] COVID-19 vaccine development and a potential nanomaterial path forward

MD Shin, S Shukla, YH Chung, V Beiss… - Nature …, 2020 - nature.com
The COVID-19 pandemic has infected millions of people with no clear signs of abatement
owing to the high prevalence, long incubation period and lack of established treatments or …

[HTML][HTML] Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers

S Nooraei, H Bahrulolum, ZS Hoseini… - Journal of …, 2021 - Springer
Virus-like particles (VLPs) are virus-derived structures made up of one or more different
molecules with the ability to self-assemble, mimicking the form and size of a virus particle but …

[HTML][HTML] Possibility of exosome‑based coronavirus disease 2019 vaccine

KH Yoo, N Thapa, BJ Kim, JO Lee… - Molecular …, 2022 - spandidos-publications.com
Abstract Coronavirus disease 2019 (COVID‑19) is a global pandemic that can have a long‑
lasting impact on public health if not properly managed. Ongoing vaccine development trials …

[HTML][HTML] Nanovaccines: a game changing approach in the fight against infectious diseases

MAH Abusalah, H Chopra, A Sharma… - Biomedicine & …, 2023 - Elsevier
The field of nanotechnology has revolutionised global attempts to prevent, treat, and
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …

[HTML][HTML] Nanocarrier vaccine therapeutics for global infectious and chronic diseases

FZ Simnani, D Singh, P Patel, A Choudhury, A Sinha… - Materials Today, 2023 - Elsevier
Immunization has the potential to become a viable weapon for the upcoming pandemic and
save millions of lives, while also dramatically lowering the high mortality rate brought on by a …